Sebastian Shaw

9PUBLICATIONS
27CO-AUTHORS
Medical infection agents (incl. prions)Major global burdens of diseaseCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Host-parasite interactions
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 24, 2026
Ablation of a maternal Cryptosporidium mRNA-binding protein results in sterile sporozoites.

|May 13, 2026
Genomic heterogeneity of NAD(P)H dehydrogenase predisposes Cryptosporidium to clofazimine resistance.

|Nov 24, 2025
Widespread genomic heterogeneity at the type II NAD(P)H dehydrogenase locus predisposes Cryptosporidium to clofazimine resistance.

Gracyn Y Buenconsejo, Sebastian Shaw, Rui Xiao

|Jun 06, 2025
Genetic crosses reveal genomic loci responsible for virulence in Cryptosporidium parvum infection.

Sebastian Shaw, Xue Li, Gracyn Buenconsejo

|Jun 03, 2024
Intestinal cDC1s provide cues required for CD4+ T cell-mediated resistance to Cryptosporidium.

Ian S Cohn, Bethan A Wallbank, Breanne E Haskins

|Dec 26, 2023
Genetic crosses within and between species of Cryptosporidium.

Sebastian Shaw, Ian S Cohn, Rodrigo P Baptista

Pageof 2

Frequent Collaborators

6 joint publications

Boris Striepen

3 joint publications

Ian S Cohn

3 joint publications

Keenan M O'Dea

2 joint publications

Isabel Roditi